Blogs

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Resource Types

Organ-on-Chip Platform: Bringing Human Biology closer to Drug Discovery and DMPK
See how an organ-on-a-chip platform can add human-relevant insight to drug discovery, DMPK and skin permeability studies. Read more.
22nd Sep, 2026
Read
Sterile Fill Finish Manufacturing at Scale: How Integrated DS+DP+FF Reduces Late-Stage Surprises
Explore how integrated sterile fill-finish manufacturing reduces transfer risks and supports clinical-to-commercial scale-up. Read the article.
15th Sep, 2026
Read
Why ADC Linker Payload Design Is the Real Differentiator in ADC Success
See how ADC linker payload design, DAR, linker choice, bystander killing, and bioconjugation shape efficacy and safety. Read the article.
15th Sep, 2026
Read
Why CDMO Outsourcing is Moving Earlier in Biologics Development
Learn why CDMO outsourcing is moving earlier in biologics development and how early CMC strategy can reduce late-stage risk. Read more.
9th Sep, 2026
Read
The New-Age CRDMO: Rethinking Drug Development Partnerships
Explore how the antibody drug conjugates market, AI, supply resilience and integrated CRDMOs are reshaping drug development outsourcing. Read more.
2nd Sep, 2026
Read
Flow Chemistry Approaches for Poorly Soluble Pharmaceutical Intermediates
Explore how flow chemistry supports poorly soluble pharmaceutical intermediates through better mixing, precipitation control, and crystallization. Read now.
28th Aug, 2026
Read
Advanced Strategies for Handling Unstable Intermediates with Flow Chemistry
See how flow chemistry helps control unstable intermediates, reduce scale-up risk, and improve process safety in pharma development. Explore now.
27th Aug, 2026
Read
Electrochemical cell design: Turning electron transfer into a practical synthetic tool
Explore electrochemical cell design, electron transfer, process development, and scalable pharmaceutical synthesis. Read the article.
10th Jul, 2026
Read
From Faster CLD to Smarter CMC Decisions: How Semi-Targeted Integration Changes the Biologics Game
See how semi-targeted integration can improve cell line development, reduce clone screening, and support biologics development. Read the article.
8th Jul, 2026
Read
India as a Global CRDMO Powerhouse: Debunking Quality Myths
Explore how India’s CRDMO quality systems, regulatory scrutiny, and biologics manufacturing capabilities challenge outdated quality myths. Read more.
8th Jul, 2026
Read